+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Herceptin 2018 U.S. Promotional Audit Report

  • ID: 4615606
  • Report
  • July 2019
  • Region: United States
  • 24 pages
  • MD Details
1 of 3

FEATURED COMPANIES

The 5 Key Questions Addressed by this Report:
  • How many physicians were reached by Herceptin through reportable promotional activity in 2018 and how does this compare to its peer set in the Breast Cancer and Gastric Cancer markets?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity?
  • How does Genentech's depth of coverage vary within key specialties (e.g., Hematology/Oncology, Pathology, General Surgery, and Medical Oncology) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Herceptin throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for Herceptin in 2018?
Data Sources and Methodology:
  • Author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, over 5 years of longitudinal data is available - covering payments to more than 1,000,000 U.S. healthcare professionals.
  • Over 1,100 paid interactions across 700 physicians made on behalf of Herceptin were carefully examined to support our analysis. In addition, interaction data from 17 peer products (i.e. Abraxane, Afinitor, Avastin, Cyramza, Fareston, Faslodex, Halaven, Ibrance, Ixempra, Kadcyla, Keytruda, Kisqali, Lynparza, Nerlynx, Perjeta, Talzenna, and Verzenio) was leveraged to provide benchmarking and market insights.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

Overview:
  • Introduction
  • Sunshine Act and Open Payments Data
  • Transfer of Value
  • Author's Platform
Herceptin - Peer Set:
  • Herceptin Peer Set Selection
Herceptin - Promotional Benchmarking:
  • Chart 1 Total Number of Physicians Reached by Specialty Type
  • Chart 2 Distribution of Physicians Reached by Specialty Type
  • Chart 3 Total Number of Payments by Type
  • Chart 4 Distribution of Payments by Type
  • Chart 5 Total Number of Payments / Week
  • Chart 6 Payment Value by Type
Herceptin - Physician Coverage by Geography:
  • Chart 7 Hematology/Oncology
  • Chart 8 Pathology
  • Chart 9 General Surgery
  • Chart 10 Medical Oncology
Herceptin - Meal Frequency:
  • Chart 11 Hematology/Oncology
  • Chart 12 Pathology
  • Chart 13 General Surgery
  • Chart 14 Medical Oncology
Herceptin - Most Engaged Physicians:
  • Table 1: Top Physicians (By Total Number of Meals) in 2018
  • Table 2: Top Speakers (By Total Number of Speaking Events) in 2018
About:
  • Background
  • Service Lines
  • Contact
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Genentech
Note: Product cover images may vary from those shown
Adroll
adroll